Journeys
Each series takes one problem and works through it: what people actually try first, what the trials support, and where the compound usually reached for sits in its own evidence. Entries are built from published research, with the sources listed. Where an entry draws on a contributor's own experience, it is published only with that account behind it and labelled as what it is — one person's result, not a study.
Night Log
Sleep problems, starting with the ones people are stuck on.
Opens on a single problem — night waking — and works through what the trials move, what they do not, and where the compound most often reached for actually sits in its own evidence.
- Waking at 3 AM: The Evidence on What Moves It — episode 1 · evidence tier: mixed
Waking at 3 AM is the insomnia pattern with the least to show for most fixes. What the trials support, and where DSIP actually sits in that record.
Lean Log
Body composition, and the arithmetic that decides it.
Starts with the plateau: why weight loss decelerates, why the explanation is usually energy balance rather than tolerance, and what the evidence says about adding items to a stalled protocol.
- The Plateau Isn't a Tolerance Problem — episode 1 · evidence tier: mixed
Weight loss stalls on GLP-1s are usually blamed on tolerance, but the arithmetic of energy balance explains better — no trial supports ad-hoc stacking as the fix.
Rebuild Log
Repair and energy peptides, read at the tier their evidence actually supports.
Starts with the mitochondrial peptides, where one compound has a phase 3 trial and a rare-disease approval and the other has no controlled human outcomes at all.
- Mitochondrial Peptides: What the Record Actually Shows — episode 1 · evidence tier: mixed
SS-31 and MOTS-c are the most sequenced mitochondrial peptides in this space. One has a phase 3 miss and a rare-disease approval; the other has no human trials at all.
What these series are not
They are not protocols and not medical advice. Schedule details, preparation and numbers live on Research Protocols, which is a reference rather than a prescriber. Every entry states its evidence tier, including when the human evidence is thin, and no entry claims causality from a single case.